InfuSystems Holdings, Inc. (INFU) vs RxSight, Inc. (RXST)
InfuSystems Holdings, Inc. and RxSight, Inc. are both Medical Devices companies. InfuSystems Holdings, Inc. is the larger, with a market value of $252.8M against $196.7M — 1.3× the size. RxSight, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 30.3×. InfuSystems Holdings, Inc. grew revenue faster over the last twelve months: 2.47% against −13.3%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −36.8%) and the higher return on invested capital (10.6% vs −63.2%). Across the 20 metrics below, InfuSystems Holdings, Inc. leads on 11 and RxSight, Inc. on 9.
Valuation
Profitability
| Metric | INFU | RXST | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.45% | 77.50% | 56.01% |
| Operating margin | 9.26% | (43.20%) | (15.03%) |
| Net margin | 5.96% | (36.80%) | (20.40%) |
| Free cash flow margin | 10.56% | (21.29%) | (7.24%) |
| Return on equity | 15.03% | (17.35%) | (15.32%) |
| Return on assets | 8.61% | (14.19%) | (19.72%) |
| Return on invested capital | 10.55% | (63.16%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack